Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Systemic diseases can cause hair loss, which is often reversible with treatment.

Oral betamethasone mini-pulses effectively treat moderate to severe alopecia areata with manageable side effects.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

Adults with alopecia areata often have empty follicular openings, while children show more honeycomb pigment patterns.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Alopecia areata patients may have higher cardiovascular risk factors, so screening for metabolic syndrome components is suggested.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Phototherapy can help treat hair loss in alopecia areata.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

ADHD stimulant medications might be linked to a specific type of hair loss called Alopecia Universalis.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Nivolumab can cause hair loss as a rare side effect.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

Alopecia is not a significant predictor of thyroid disease when age and sex are considered.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

The guideline provides recommendations for managing alopecia areata effectively.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Phototherapy effectively treats certain alopecia areata types, especially if started early.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.